NCT04194320View on ClinicalTrials.gov

Dexamethasone Versus Nalbuphine as Adjuvants in Brachial Plexus Block

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

December 1, 2019

Primary Completion Date

May 5, 2020

Study Completion Date

June 15, 2020

Conditions
Anesthesia
Interventions
PROCEDURE

Ultrasound (US) guided supraclavicular brachial plexus block

Using 8 mg dexamethasone or 10 mg nalbuphine as adjuvants to (Lidocaine 2% + bupivacaine 0.5% 1:1 mixture) in ultrasound (US) guided supraclavicular brachial plexus block

Trial Locations (1)

055

Faculty of medicine, Zagazig University, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV

NCT04194320 - Dexamethasone Versus Nalbuphine as Adjuvants in Brachial Plexus Block | Biotech Hunter | Biotech Hunter